Functional Outcome and Complications After Global Unite ® Prostheses

• Conditions: Proximal Humeral Fracture; Osteoarthritis of the Shoulder
• Interventions: Procedure: Global Advantage; Procedure: Global Unite total shoulder arthroplasty; Procedure: Global Unite hemiarthroplasty; Procedure: Global FX

• Registration Number: NCT03097406
• Lead Sponsor: Herlev and Gentofte Hospital

Brief Summary

This study aims to investigate the shoulder function of patients with osteoarthritis or a fracture of the upper extremity after surgery with the Global Unite shoulder system.

The majority of fractures of the humerus are non-surgically treated, but for the complex cases where the fracture is irreparable (1), the treatment choice is a shoulder prosthesis called a hemiarthroplasty. Hemiarthroplasty has been associated to less pain and more quality of life , (2,3) but no difference in range of motion is reported when compared to non-surgically treatment of complex humeral fractures. (2,3,4)

One of the important steps in surgery of a fractured humerus is the fixation of the bone fragments in an anatomically correct position as previous studies have shown that complications related to the fixation and healing of bone fragments occurred in 11 % of patients treated with a hemiarthroplasty . The Global Unite hemiarthroplasty introduces a new feature, which allows the surgeon to more closely attach the bone fragments.

Patients with osteoarthritis and fractures of the humerus will be included from two hospitals, Herlev and Køge University Hospital. A total of 88 patients, 44 osteoarthritis and 44 fracture patients, are included. The patients will be followed two years after surgery and will be seen a total of four times postoperatively, where the function of the shoulder will be examined by questionnaires concerning shoulder function and quality of life, by a motion examination and by x-ray. The outcome of these examinations will be compared to the functional outcome of patients that have received different shoulder prostheses for the same diagnoses at Herlev and Køge University Hospital. The patients will undergo two radiographic scans after surgery, to determine whether or not bone fragments remain in an anatomically correct position in the patients with a fracture of the proximal humerus. A special focus will be on the function of the shoulder in patients with bone fragments that are not in an anatomically correct position. Furthermore, complications and the need of reoperation were registered during the two-year follow-up period.

The aims of this study is to

* Determine the function of the shoulder in patients receiving the Global Unite prosthesis due to either osteoarthritis or fracture of the humerus.

* To compare these results with results from patients previously treated with a different prosthesis designs

* To determine the influence of the fixation of bone fragments in the postoperative function in fracture patients.

Detailed Description

The study was based on data from Køge and Herlev University Hospital. All patients that fit the inclusion criteria and had an indication for shoulder replacement where included and the study started on the 1st of January 2017.

Aim

* To determine 2-year postoperative outcome, complications and revision rates in patients receiving a Global Unite

* To compare the postoperative outcome to patients from a in matched control group

* To determine the influence of tuberosity placement and migration on functional outcome in patients with a fracture of the proximal humerus.

The trauma mechanism of the fractures and health status of the patients were determined upon arrival. A preoperative CT-scan was performed in all fracture patients for preoperative planning. A CT-scan was also performed preoperatively in the osteoarthritis patients to determine the degree of bone degeneration. An x-ray was performed right after surgery, 3 months and 24 months postoperatively.

The patients included received a Global Unite hemiarthroplasty in the fracture situation and a Global Unite total shoulder in osteoarthritis patients. The patients received standardized postoperative analgesic treatment and physiotherapy rehabilitation and all patients had postoperative follow-up 3, 6 months, 1-year and 2-year after surgery. The outcome at the follow-up was determined by using Oxford Shoulder Score, Constant-Murley score, EQ-5-D questionnaire and Western Ontario Osteoarthritis of the Shoulder index

Factors like American Society of Anesthesiologists score, body-mass index, smoking, alcohol, medication and comorbidity were registered. Furthermore time from injury to surgery, surgery time, length of hospital stay, complications (osteonecrosis, infection, loosening), revision, discharge type, pain score and analgesia were reported. The preoperatively function was only registered for osteoarthritis patients.

The study was performed as a prospective cohort study with a historic control group. The fracture patients submitted for a Global Unite from February 2017 were compared to fracture patients receiving the Global FX at Herlev and Køge Hospital from 2013 to 2016 and the osteoarthritis patients receiving a Global Unite total shoulder were compared to patients receiving a Global Advantage at Herlev Hospital from 2013-2016. 44 patients were included in the control and the intervention groups, of both diagnoses, to obtain power of 80 % in power calculations based on Constant-Murley score. This equals a total of 88 patients in the intervention groups and 88 patients in the control groups. It was estimated that it would take 2 to 3 years to include osteoarthritis- and fracture-patients in this study.

All surgery was performed by 5 senior consultants at Herlev Hospital and 2 senior consultants at Køge Hospital. The postoperative functional outcome of patients in the first half of the study was compared to the outcome of patients in the last half to determine a possible learning curve. The follow-up was performed by one independent physician

Study Timeline

• Study Start: 2017-01-01
• Study First Submitted: 2017-03-15
• Study First Submitted QC: 2017-03-27
• Study First Posted: 2017-03-31
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-27
• Last Update Posted: 2019-08-28
• Primary Completion: 2021-01-01
• Study Completion: 2022-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Osteoarthritis patients:

• Pronounced osteoarthritis
• physician-assessed need of surgery
• Surgery at Herlev University Hospital

Fracture patients:

• Luxation fractures
• 4-part fractures
• Displaced 3-part fractures
• Headsplit fractures
• Treated at Herlev University Hospital or Køge University Hospital

Control group:

• Surgery from 2013-2017
• Treated for osteoarthritis with Global Advantage
• Osteoarthritis surgery at Herlev University Hospital
• Treated with Global FX due to fracture of the proximal humerus
• Global FX treatment at Herlev or Køge University Hospital

Read More

Exclusion Criteria

• Patients not living in Denmark
• Two-part fractures of the proximal humerus
• Patient without a Danish civil registration number
• Patients younger than 50
• Revision surgery
• Previous arthroplasty procedures in the same shoulder
• Deceased patients

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Osteoarthritis control group	Global Advantage	Patients with osteoarthritis (2013-2016) at Herlev Hospital treated with a Global Advantage
Osteoarthritis group	Global Unite total shoulder arthroplasty	Patients with osteoarthritis (2017-2019) at Herlev Hospital treated with Global Unite total shoulder arthroplasty
Fracture group	Global Unite hemiarthroplasty	Patients with a fracture of the proximal humerus (2017-2019) at Køge and Herlev Hospital treated with Global Unite hemiarthroplasty
Fracture control group	Global FX	Patients with a fracture of the proximal humerus (2013-2016) at Køge and Herlev Hospital treated with Global FX hemiarthroplasty

Primary Outcome Measures

Name	Time	Method
Functional outcome (Western Ontario Osteoarthritis of the Shoulder (WOOS))	24 months after surgery	The WOOS questionnaire is used to measure the patient-reported functional outcome for the patients. The outcome will be compared with outcome of patients that previously received Global FX or Global Advantage for fracture or osteoarthritis, respectively.
Functional outcome (Constant-Murley Score (CMS))	24 months after surgery	CMS is used to measure the functional outcome for the patients. The outcome will be compared with outcome of patients that previously received Global FX or Global Advantage for fracture or osteoarthritis, respectively
Functional outcome (Oxford Shoulder Score (OSS))	24 months after surgery	The OSS questionnaire is used to measure the patient-reported functional outcome. The outcome will be compared with outcome of patients that previously received Global FX or Global Advantage for fracture or osteoarthritis, respectively

Secondary Outcome Measures

Name	Time	Method
Tuberosity migration or vanishing in fracture patients	Baseline CT-scan, x-rays 3 and 24 months after surgery	A preoperative CT-scan will be performed and postoperative x-rays will be performed to determine whether or not the tuberosities have migrated or vanished in the fracture patients treated with Global Unite hemiarthroplasty

Trial Locations

Locations (2)

Køge University Hospital; 🇩🇰 Koge, Denmark

Herlev University Hospital; 🇩🇰 Herlev, Copenhagen, Denmark